RAISSA HILL: Open Payments
NPI 1346351566 · STOCKTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,929 in 204 payments from 34 companies in 2025. Trend: 2023 $2,768 · 2024 $2,889 · 2025 $3,929
Food & beverage: $3,912Entertainment: $17
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $545 |
| ABBVIE INC. | 25 | $353 |
| Lilly USA, LLC | 20 | $344 |
| Otsuka America Pharmaceutical, Inc. | 18 | $250 |
| Amgen Inc. | 10 | $209 |
| Vanda Pharmaceuticals Inc. | 9 | $202 |
| AstraZeneca Pharmaceuticals LP | 9 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $181 |
| Lundbeck LLC | 8 | $177 |
| Axsome Therapeutics, Inc. | 6 | $150 |
Products named: REXULTI, Ozempic, MOUNJARO, HETLIOZ, Wegovy, Kerendia, UBRELVY, Auvelity.
Industry payments across CA — which companies pay providers there.
